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Abstract
Background: Isolated angiitis of the central nervous system (IACNS) is a rare but severe vascular disease, which
could present like an isolated inflammatory lesion on magnetic resonance imaging (MRI). To date, only a few such
cases with tumor-like IACNS have been reported.
Case Presentation: A 35-year-old woman presented with headache and left-sided weakness. MRI scans initially
mislead us to a diagnosis of glioblastoma (GBM). Surgery was performed. The mass was sub-totally resected.
Pathological examination confirmed a cerebral vasculitis. Radiological features, such as disproportionate mass effect,
striped hemorrhage and abnormal enhancement of adjacent vessels, could be helpful to distinguish a tumor-like
IACNS from a GBM. Single therapy with high doses of steroid did not improve the patient’s condition. Combined
therapy with prednisolone and cyclophosphamide showed great benefit to the patient. No relapse occurred during
the period of 18 months follow-up.
Conclusions: Although a tumor-like IACNS has no established imaging features, a diagnosis of tumor-like IACNS
should be suspected when MRI shows inappropriate presentations of a tumor. Greater awareness of this potential
manifestation of IACNS may facilitate more prompt diagnosis and treatment.
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Background
Isolated angiitis of the central nervous systmen (IACNS)
represents a rare and poorly understood form of vascu-
lar inflammatory disease restricted to the brain and
spinal cord. An average annual incidence rate of 2.4
cases per 1,000,000 person-years was found by a report
from US [1]. Histopathology usually reveals granuloma-
tous inflammation affecting arterioles and small arteries
of the parenchyma and/or leptomeninges [2]. Non-spe-
cific clinical manifestations and various imaging findings
often lead to an incorrect or delayed diagnosis and
treatment [3], particularly for an extremely rare form of
tumor-like lesion. In this report, we describe a woman
with tumor-like IACNS that was initially mistaken for
glioblastoma (GBM).
Case Presentation
In April 2008, a 35-year-old woman was admitted to our
hospital due to headache and left-sided weakness over
the preceding 1 month. The headache was diffuse and
did not have a burning or stabbing sensation. The weak-
ness of the left arm and jaw was mild. Her mental status
was clear with normal orientation and alertness. It was
negative in speech disorder and perceptual disturbance.
A review of systems at the time of presentation revealed
no additional symptoms, except for mild hypomnesis.
There was no history of alcohol or illicit drug use. Toxic
exposure history was negative. On neurologic examina-
tion, the patient presented moderate weakness on the left
side. An equivocal Babinski sign was elicited in the left
foot. Findings on physical examination were normal.
Admission MRI study of the brain (Figure 1) revealed a
tumor-like mass with edema and enhancement, which
was initially suspected to be a malignant glioma. The
patient subsequently underwent a craniotomy. Because a
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lesion was subtotally resectted (Figure 2a). Intraoperative
pathologic examination showed no tumor cells but
inflammatory cells and necrosis, which confirmed the
surgeon’sj u d g m e n t .T h ep a t i e n t ’s blood and cerebrosp-
inal fluid (CFS) samples were collected at the end of
operation. Concerned of a possible diagnosis of multiple
sclerosis, a 3-day high-dose (1,000 mg daily) pulse ther-
apy of methylprednisolone was initiated. Two weeks after
surgery, the first postoperative MRI showed bilateral
hyper-intensity in the frontal and parietal sub-cortex (Fig-
ure 2b). Results of the serum and CSF tests were as fol-
lows: Routine blood tests, as well as blood rheumatologic
tests, blood immunoglobulins, blood antinuclear antibo-
dies, antiphospholipid antibodies, and antineutrophil
cytoplasmic antibody, were normal. Analysis of the CSF
showed the increases of total protein (170 mg/dl; normal
< 45 mg/dl) and myelin basic protein (MBP) (2.23 nmol/
l; normal < 0.55 nmol/l). The immunoglobulin (Ig) G in
CSF index was remarkably increased (20.5 mg/dl; normal
< 6 mg/dl). Oligoclonal bands (OB) were negative. No
marked increase in antiviral titers in the serum or CSF
was observed. With great interests, we carefully
rechecked all the paraffin sections of the mass, and a big
surprise for us, we eventually found the evidence for cer-
ebral vasculitis (Figure 3). Combined therapy with steroid
and immunosuppressant was initiated immediately after
the diagnosis as follows: intravenous prednisolone 1000
mg/d for 3 days, 500 mg/d for 3 days, 250 mg/d for 3
days, 125 mg/d for 3 days, followed by oral prednisolone
60 mg/d and cyclophosphamide 125 mg/d for 2 weeks.
Six weeks after surgery, the patient’s neurological symp-
toms gradually disappeared and repeated MRI confirmed
remarkable improvement of affected brain (Figure 2c).
Figure 1 Axial T2-weighted MR image (a) showing a mass with
mixed signal intensity and a surrounding edema area. On the
T1-weighted image after the administration of contrast material (b
and c), the mass has an inhomogeneous enhancement. Sagittal T1-
weighted MR image without contrast (d) depicting a striped
hemorrhage.
Figure 2 Axial contrast-enhanced MR image showing a partial
resection of the lesion. (a) T1-weighted image showing the newly
developed hyper-intensity diffusing to the opposite side (b). Great
improvement after the treatment (c). T1-weighted MR images with
contrast showing some abnormally enhanced vessels (arrows) (d).
Figure 3 Pathologic findings showing massive perivascular
lymphocyte cuffing (HE stain, × 200).
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and cyclophosphamide, and no relapse occurred during
an 18-month follow-up.
Discussion
IACNS, which was first reported as early as 1952 [4],
can occur mostly when patients are 30 to 50 years old
[3]. To date, a few such cases with tumor-like IACNS
have been reported. Its etiology and pathogenesis are
still unknown. It is very possible that viral infections
initiate the inflammatory process that somehow
becomes self-sustaining [5]. It is also speculated that
there may be a genetic predisposition in certain indivi-
duals leading to an enhanced risk of a vasculitic process
when there is an exposure to a particular antigen that
“sets off” the immune system [6].
Clinical onset of IACNS is usually subacute, but it can
have acute onset with rapid progress within a few days
or weeks. The most frequent clinical manifestations at
presentation are headache, altered cognition, hemipar-
esis or persistent neurological deficit or stroke [1]. Sub-
arachnoid hemorrhage could be the first presentation
of IACNS [7]. Less common complaints are aphasia,
transient ischemic attack, ataxia, dysphasia, nausea or
vomiting, loss of memory, seizure disorder, dyslalia,
hypomnesia and paralysis. Interestingly, there have been
so far two case studies reporting psychiatric symptoms
in two patients with IACNS [8,9]. But all the symptoms
above-mentioned are non-specific for diagnosis.
With regard to imaging characteristics, IACNS always
presents a challenge in radiographic diagnosis. Its MRI
findings are highly variable, ranging from multiple irre-
gular white matter changes to intracerebral hemorrhages
[7,10]. The present case demonstrated a large monofocal
lesion with disproportionate mass effect, striped hemor-
rhage, and abnormal enhancement of adjacent vessels
(Figure 2d) on MRI. Possibly some main artery and its
branches were involved. So, given a tumor-like lesion
with these characteristics on neuroimages, we suggest
an IACNS should be considered in the differential diag-
nosis. This would be an important lesson learnt from
this case. Several studies [3,11,12] to some extent
emphasized the similar viewpoints. In addition, Campi
et al. [13] indicated that VRPVS (dilatation of Virchow-
Robin perivascular spaces), which signify severe but
reversible perivascular inflammation causing blood-brain
barrier disruption and injury of surrounding white mat-
ter, might likely be specific for vasculitis. Unfortunately,
this did not show up in this case.
Moore [14] recommended a widely received standard
for the diagnosis of IACNS in which he emphasized the
importance of cerebral angiography and biopsy based on
careful exclusion of other diseases. When cerebral
angiography shows stenosis or occlusion of the cerebral
vessels, brain biopsy should be performed [15]. How-
ever, the classic appearance of alternating narrowing
and dilatation is not completely specific and has been
observed in only 25% of patients with IACNS; the angio-
gram is normal in up to 40% of pathologically documen-
t e dc a s e s[ 1 6 ] .I ts h o u l db ei n d i v i d u a l i z e dt om a k ea
differential diagnosis [3,14,17]. IACNS may clinically
mimic encephalitis, multiple sclerosis, acute dissemi-
nated encephalomyelitis, myelinoclastic diffuse sclerosis,
cerebral infarction, leukoencephalopathy or other brain
tumors, when they present isolated lesions on MRI. It
may be difficult to differentiate between IACNS and
demyelinating or inflammatory diseases [18-20], because
of similar symptoms, clinical exam and laboratory find-
ings. Besides, it is also not easy to differentiate between
IACNS and lymphoma when there are multiple-enhan-
cing lesions with vasogenic edema on neuroimagines.
Against the above, only biopsy allows a definite diagno-
sis. But sometimes, a single isolated negative biopsy
does not necessarily exclude IACNS [21,22] or second-
ary CNS vasculitis. In that case, empirical treatment
should be administrated.
No clinical trials have been performed in patients with
IACNS, nor is it possible to draw firm conclusions from
the current study because of the non-standardized nat-
ure of the treatment protocols used in these cases.
Fountain et al. [23] reported a case with IACNS con-
trolled by cyclophosphamide alone, while Carandang C
and Grant A reported a female patient with IACNS
responding to steroids alone [9]. But Barron et al. [24]
indicated that steroid therapy alone failed to improve
the condition. This finding is consistent with ours.
Others recommended combination therapy consisting of
prednisone and cyclophosphamide for at least 1 year
[25,26]. In addition, Salvarani et al. [27] indicated that
patients with IACNS which also have vascular deposits
of b-peptide generally respond well to immunosuppres-
sive treatment. However, the present case demonstrated
good effects of immunosuppressant to patient without
indication of amyloid protein deposition. Currently,
most authors consent to combined and long-term ther-
apy in treating IACNS. It is strongly suggested [1,28]
that immunosuppressive therapy should be judiciously
employed in patients with IACNS, based on the clinical
features (any co-morbid conditions, the potential for
neurological recovery, et al). In our case, the initial
pulse therapy with steroid failed to prevent the rapid
progress of vasculitis. Only combined therapy with
cyclophosphamide improved her condition dramatically.
The prognosis of IACNS varies greatly and could be
from months to years [1,11,17]. Untreated IACNS
usually causes fatal outcome. Greater awareness of these
potential manifestations of IACNS may facilitate more
accurate diagnosis and prompt treatment.
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In conclusion, we suggest that correct diagnosis and
appropriate treatment of tumor-like IACNS should be
essential for prognosis. When the MRI shows a tumor-
like subcortical lesion with disproportionate mass effect,
and/or striped hemorrhage and/or abnormal enhance-
ment of adjacent vessels, an IACNS should be include
in the differential diagnosis. When high doses of steroids
show no effect to the patient with tumor-like IACNS,
combined treatment with cyclophosphamide followed by
long term oral therapy is recommended.
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